Binx Health
Boston
About Binx Health
Binx Health is committed to broadening convenient and equitable access to healthcare. The company's point-of-care diagnostic solutions empower its partners to overcome traditional barriers to care, extend their outreach, and deliver exceptional patient experiences. The binx io point-of-care molecular platform marks a significant milestone as the first FDA-cleared, CLIA-waived system for detecting chlamydia and gonorrhea in both males (urine) and females (vaginal swabs). It delivers results comparable to those of central lab performance, typically within about thirty minutes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $286.7M
- Funding stage: Late Stage Venture
- Last round: Series F (Apr 2024)
- Website: mybinxhealth.com
- Phone: +44 (0)1225 717930
Industries & Categories
Health Care, Health Diagnostics, Medical Device, Mobile
Social Profiles
Canonical: https://fsome.com/organization/binx-health-82314 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.